Clinical Trial Update: Study of Dalpiciclib Isethionate Plus Pyrotinib Maleate in the Treatment of Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of dalpiciclib isethionate and pyrotinib maleate for advanced esophageal squamous cell carcinoma, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Dalpiciclib Isethionate (dalpiciclib)
• Pyrotinib maleate (pyrotinib)

Snippet

Sponsor: Peking University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING